Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium lauryldiaminoethylglycine gargle study for reduction of salivary SARS-CoV-2
jRCTs051210107Completed
- Sponsor
- Saraya
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sodium lauryldiaminoethylglycine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Saraya. Started Nov 2021; status: completed.
02
Drugs
sodium lauryldiaminoethylglycine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCTs051210107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051210107.